60 Degrees Pharmaceuticals develops and commercializes new medicines to treat and prevent infectious diseases.
60 Degrees Pharma has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2025.
60 Degrees Pharma is headquartered in Washington, United States.
60 Degrees Pharmaceuticals develops and commercializes new medicines to treat and prevent infectious diseases.
60 Degrees Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"60 Degrees Pharma — Funding & Investors." VCBacked, July 15, 2025, https://www.vcbacked.co/company/60-degrees-pharma. Accessed August 13, 2026.
VCBacked. (2025). 60 Degrees Pharma — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/60-degrees-pharma
{{cite web |title=60 Degrees Pharma — Funding & Investors |url=https://www.vcbacked.co/company/60-degrees-pharma |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated